Feb 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.19 6.99 10.91
(+17.3 pct) (+3.2 pct) (+14.0 pct)
Operating 835 mln 467 mln 818 mln
(+78.7 pct) (-65.7 pct) (+0.4 pct)
Recurring 869 mln 546 mln 674 mln
(+59.2 pct) (-60.1 pct) (-36.8 pct)
Net 565 mln 345 mln 450 mln
(+63.9 pct) (-59.7 pct) (-36.5 pct)
EPS 69.81 yen 43.56 yen 55.58 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T